Načítá se...

Inhibitors of bromodomain and extra‐terminal proteins for treating multiple human diseases

Clinical development of bromodomain and extra‐terminal (BET) protein inhibitors differs from the traditional course of drug development. These drugs are simultaneously being evaluated for treating a wide spectrum of human diseases due to their novel mechanism of action. BET proteins are epigenetic “...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Med Res Rev
Hlavní autoři: Kulikowski, Ewelina, Rakai, Brooke D., Wong, Norman C. W.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7756446/
https://ncbi.nlm.nih.gov/pubmed/32926459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/med.21730
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!